THOUSAND OAKS Calif. March 21 2016 PRNewswire &160;Amgen NASDAQAMGN today announced that it will present 19 abstracts related to its cardiovascular portfolio including new detailed data &160;evaluating Repatha&174; evolocumab in patients with h...
↧